# OnCo record bespoke-crc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/bespoke-crc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "bespoke-crc", "NCT04264702" ;
  schema:name "BESPOKE CRC"@en ;
  schema:alternateName "BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer"@en ;
  schema:description "Natera's US study in which 1,788 people with bowel cancer had Signatera blood tests after surgery and their doctors could act on the result; it records what changed and what happened, but does not randomise anyone."@en ;
  schema:url <https://onco.cc/trials/bespoke-crc/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04264702> ;
  onco:status "active" ;
  onco:tag "ctdna-roadmap" ;
  onco:phase "observational" ;
  onco:related <https://onco.cc/trials/circulate-us/>, <https://onco.cc/roadmaps/ctdna-tests/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:drugs <https://onco.cc/drugs/signatera/> ;
  onco:companies <https://onco.cc/companies/natera/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> .